<DOC>
	<DOCNO>NCT01353066</DOCNO>
	<brief_summary>Background : Type 2 Diabetes Mellitus ( T2DM ) associate increase burden cardiovascular disease ( CVD ) . Multifactorial intervention necessary reduce CV risk T2DM . Bariatric surgery appear alternative multifactorial intervention T2DM associate obesity . Data show , clinical trial aim control CVRF T2DM may translate reduction CV event . Hypothesis : Intensive medical treatment ( IMM ) include Roux-en-Y Gastric Bypass ( RYGBP ) could superior control progression subclinical atherosclerotic disease , evaluate carotid ultrasound , subject T2DM BMI 30.0 34.9 kg/m2.The primary aim study To compare effect intensive medical treatment ( IMM ) include Roux-en-Y Gastric Bypass ( RYGBP ) IMM alone progression carotid intima medium thickness ( CIMT ) 24 month entry trial relative baseline.Methodology : Two-year Randomized Clinical Trial , include 240 patient</brief_summary>
	<brief_title>Gastric Bypass Versus Best Medical Treatment Progression Carotid-intima Media Thickness Type 2 Diabetes Mellitus ( T2DM )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>Age 35 65 year eligibility visit . Diagnosed T2DM least 6 month prior enrollment , active care doctor least six month prior enrollment , HbA 1c &gt; 7.0 % . Current treatment T2DM consist multiple dos insulin with/without hypoglycemic agent hypoglycemic agent plus basal insulin . Optimization diabetes medical treatment prior inclusion study would perform base best medical practice . Body Mass Index ( BMI ) &gt; 30.0 kg/m2 &lt; 34.9 kg/m2 eligibility visit . Willingness accept random assignment either treatment group . Expect live work within approximately one hour 's traveling time study clinic duration twoyear trial . Willingness comply followup protocol successful completion runin . Written informed consent . Cardiovascular event ( myocardial infarction , acute coronary syndrome , coronary artery angioplasty bypass , stroke ) past six month . Current evidence congestive heart failure ( grade II IV ) , angina pectoris , symptomatic peripheral vascular disease advance cardiovascular disease . History severe hypoglycemic episode associate medical treatment type 2 DM Cardiac stress test indicating surgery would safe Pulmonary embolus thrombophlebitis past six month . Cancer kind ( except basal cell skin cancer cancer situ ) unless document diseasefree five year . Significant anemia history coagulopathy . Serum creatinine &gt; 1.5 mg/dl . Serum total bilirubin alkaline phosphatase great upper limit normal , ALT great twice upper limit normal . History previous surgery contraindicate gastric bypass criterion surgical team . Gastric duodenal ulcer past six month . History intraabdominal sepsis ( except uncomplicated appendicitis diverticulitis six month prior enrollment ) . Previous organ transplantation . Selfreported HIVpositive status , active tuberculosis , active malaria , chronic hepatitis B C , cirrhosis , inflammatory bowel disease . Currently pregnant nursing , plan become pregnant next two year . History alcohol drug dependency ( exclude caffeine nicotine ) past five year Active psychosocial psychiatric problem likely interferer adherence protocol . Score 17 high CESD ( depression scale ) . Current participation conflict research protocol . Presence chronic debilitating disease would make adherence protocol difficult . 12lead EKG indicate surgery intensive medical treatment would safe . Diagnosed diabetes 15 year ago . Positive GAD antibody</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Type 2 Diabetes Mellitus</keyword>
	<keyword>BMI 30.0-34.9 kg/m2</keyword>
</DOC>